Fatal hyalohyphomycosis with cutaneous involvement caused by Purpureocillium lilacinum in an immunocompromised patient with bullous pemphigoid.
Journal
Acta bio-medica : Atenei Parmensis
ISSN: 2531-6745
Titre abrégé: Acta Biomed
Pays: Italy
ID NLM: 101295064
Informations de publication
Date de publication:
01 07 2021
01 07 2021
Historique:
received:
28
06
2020
accepted:
30
11
2020
entrez:
2
7
2021
pubmed:
3
7
2021
medline:
13
7
2021
Statut:
epublish
Résumé
Emergent pathogen as Purpureocillium lilacinum are becoming cause of morbidity and mortality in our population, especially in immunocompromised patients. We describe a case of hyalohyphomycosis in a diabetic man under systemic steroid treatment for a bullous pemphigoid. Treatment with different antimycotic drugs were ineffective and infection spread diffusely, leading to deterioration of general conditions and ultimately death. The aim of this article is to increase awareness of clinicians about this uncommon, but frequently fatal refractory mycotic infection.
Identifiants
pubmed: 34212928
doi: 10.23750/abm.v92i3.10100
pmc: PMC8343759
doi:
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e2021139Références
Antimicrob Agents Chemother. 2013 Nov;57(11):5271-6
pubmed: 23939898
Eur J Clin Microbiol Infect Dis. 1999 Nov;18(11):814-8
pubmed: 10614958
Antimicrob Agents Chemother. 2008 Aug;52(8):2926-8
pubmed: 18519716
Clin Microbiol Infect. 2006 Oct;12(10):948-60
pubmed: 16961630
N Engl J Med. 2014 Jul 10;371(2):150-60
pubmed: 25006721